What should we expect from multiple sclerosis therapy? Results of an integrated analysis of delayed-release dimethyl fumarate pivotal trials.
Neurosciences, Reproductive and Odontostomatological Sciences Department, Federico II University, Naples, Italy.
R
0000-0001-6388-8180
R
Lanzillo
D000069462:Dimethyl Fumarate; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents; D009103:Multiple Sclerosis; D020529:Multiple Sclerosis, Relapsing-Remitting
D007166:Immunosuppressive Agents; D000068717:Glatiramer Acetate; D000069462:Dimethyl Fumarate